NanoString Launches New nCounter Pro Analysis System
NanoString Technologies (NASDAQ: NSTG) has launched the nCounter® Pro Analysis System, enhancing its instrument platform with advanced cybersecurity features and minimal bioinformatics requirements. This system, validated for a 21 CFR Part 11 environment, streamlines gene expression profiling and offers cloud-based analytics through ROSALIND, significantly improving data management and analysis. With over 5,300 peer-reviewed publications since the nCounter's 2008 inception, this release aims to support biomanufacturing and translational research, showcasing NanoString's commitment to innovation.
- Launch of the nCounter Pro Analysis System enhances data security with modern encryption features.
- The system simplifies workflow and offers automated gene expression profiling.
- Validated for 21 CFR Part 11, appealing to pharmaceutical customers.
- Cloud-based analytics through ROSALIND saves researchers time on data analysis.
- The nCounter platform is supported by over 5,300 peer-reviewed publications.
- None.
Advanced Cybersecurity with State-of-the-Art Encryption Features and Biomanufacturing Compliance Enablement
The nCounter Pro Analysis System offers a seamless workflow and simple, fully automated gene expression profiling with direct digital detection. Additionally, the nCounter Pro Analysis System has been validated to enable a 21 CFR Part 11 environment, relevant in particular to many pharmaceutical customers. Advanced, cloud-based analytics specific to nCounter Pro data is available through ROSALIND, a collaborative data analysis platform. This enables complex data sets to be more easily managed and analyzed without the need for programming knowledge, saving significant time to achieve results and biological insights.
“This launch represents NanoString’s commitment to developing innovative tools to advance our understanding of biology," said
The nCounter Pro Analysis System is compatible with the GeoMx® Digital Spatial Profiler, which provides spatial context for the biological data, creating an entirely new dimension of knowledge. Learn more about the nCounter Pro Analysis System at
Since the nCounter platform was released in 2008, the technology has been cited in over 5,300 peer-reviewed publications. For more information about the nCounter Pro Analysis System, visit www.nanostring.com/nCounterPro.
The development of new and innovative pre-built panels continues to drive the expansion of the nCounter platform across a broad range of research applications. The company has added panels addressing interests throughout research, clinical studies, and biomanufacturing, including new panels for Stem Cell Characterization, Host Immune Response, Immune Exhaustion, TCR Diversity, Canine IO, and most recently, Cardiovascular Disease Pathophysiology.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220407005313/en/
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768
Source:
FAQ
What is the nCounter Pro Analysis System launched by NSTG?
How does the nCounter Pro improve data analysis for researchers?
What regulatory compliance does the nCounter Pro support?
When was the nCounter Pro Analysis System announced by NanoString?